Abiopharma

🔍 Schlacks William J. (Director)

Company: EquipmentShare.com Inc (EQPT)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Class A Common Stock at $21.47 per share (Direct)
  Date: 2026-06-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By EQS Heritage Holdings LLC | shares_owned_after: 13,592,263.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By EQS Legacy Holdings LLC | shares_owned_after: 714,285.00 | Footnotes: F3

Footnotes:

• F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.10 to $21.55 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• F2: The reporting person is a managing member of EQS Heritage Holdings LLC and, jointly with Jabbok Schlacks, has controlling voting and dispositive power with regard to the shares held by the entity. The reporting person disclaims beneficial ownership of such securities for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
• F3: The reporting person is a managing member of EQS Legacy Holdings LLC and, jointly with Jabbok Schlacks, has controlling voting and dispositive power with regard to the shares held by the entity. The reporting person disclaims beneficial ownership of such securities for purposes of Section 16, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.